Screening Of Adult urBan pOpulation To diAgnose Heart Failure

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03526601

Acronym

SOBOTA-HF

Enrollment

2861

Registered

2018-05-16

Start date

2017-05-10

Completion date

2018-09-30

Last updated

2018-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

heart failure, prevalence

Brief summary

Screening Of adult urBan pOpulation To diAgnose Heart Failure (SOBOTA-HF) is a cross-sectional prevalence study in a representative sample of Murska Sobota residents aged 55 years or more. Individuals will be invited to participate in a screening with NT-proBNP. All subjects with NT-proBNP ≥ 125 pg/mL will be invited for a diagnostic visit that will include history and physical examination, electrocardiogram, echocardiography, ankle brachial index, pulmonary function tests, body composition measurement, physical performance tests and questionnaires. To validate the screening procedure, a control group (NT-proBNP \< 125 pg/mL) will undergo same diagnostic evaluation. An external center will validate echodardiography exams and the HF diagnosis will be adjudicated within an independent HF expert panel. Overall and age specific HF prevalence will be calculated in individuals ≥ 55 years and extrapolated to the whole population.

Interventions

DIAGNOSTIC_TESTNT-proBNP, echocardiography

screening

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

55 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* age \>55 * living in Murska Sobota * part of representative sample as selected by Statistical Office of the Republic of Slovenia

Exclusion criteria

NONE.

Design outcomes

Primary

Measure	Time frame
heart failure diagnosis as per 2016 ESC guidelines	at diagnostic visit

Countries

Slovenia

Contacts

Primary ContactMitja Lainscak, MD, PhD

mitja.lainscak@guest.arnes.si+386 2 5123 733

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026